NVWM LLC’s Medpace MEDP Stock Holding History

NVWM LLC’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-73	Closed	-$17.7K	–	446
2023 Q3	$17.7K	Sell	73 -517	-88%	-$132K	0.01%	286
2023 Q2	$142K	Hold	590	–	–	0.05%	198
2023 Q1	$111K	Buy	590 +547	+1,272%	+$113K	0.04%	211
2022 Q4	$9.13K	Buy	+43	New	+$8.59K	﹤0.01%	331

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

NVWM LLC's MEDP Position: Q4 2023 in Review

NVWM LLC sold out of Medpace (MEDP) in Q4 2023, closing a stake of 73 shares — an estimated $17.7K sold.

NVWM LLC first reported a position in MEDP in Q4 2022 and held it in 4 quarters. The position peaked at $142K in Q2 2023. 544 funds tracked by Wall St. Rank hold MEDP as of Q4 2023.

NVWM LLC reported no remaining Medpace position as of Q4 2023 after selling out during the quarter.
NVWM LLC sold 73 Medpace shares in Q4 2023, an estimated $17.7K.
NVWM LLC first reported a position in Medpace in Q4 2022 and held it in 4 quarters.
NVWM LLC's Medpace position peaked at $142K in Q2 2023.
544 funds tracked by Wall St. Rank held Medpace as of Q4 2023.

Based on NVWM LLC's 13F filing for Q4 2023, filed 8 Feb 2024.